Condition

Toxoplasmosis, Cerebral

ClinicalTrials.gov condition label

Clinical trials9

Recruiting0

Common interventions8

Lead sponsors shown5

Clinical trials

9 shown

Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)NCT07044037 · 2024-07-01

A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive PatientsNCT00000973

Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected PatientsNCT00000643

Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic EncephalitisNCT00000794

A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii InfectionNCT00000666

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDSNCT00000674

A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDSNCT00000966

A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-SulfadiazineNCT00001994

Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of RelapseNCT00002064

Common interventions

PyrimethamineDRUG7 Leucovorin calciumDRUG5 AtovaquoneDRUG2 ClindamycinDRUG2 AzithromycinDRUG1 ClarithromycinDRUG1 SulfadiazineDRUG1 ZidovudineDRUG1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)5 Centre Hospitalier de Saint-Denis1 Glaxo Wellcome1 Palo Alto Medical Foundation1 Pfizer1

Trial status mix

COMPLETED9

Phase mix

NA4

PHASE12

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.